This bipartisan legislation prevents further cuts, provides a modest inflationary adjustment to help ease the cost of care, ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Robert F. Kennedy Jr., the HHS secretary nominee, has said he is not antivaccine, but he has a track record of casting doubt ...

After several days of worry that the global AIDS program might come to abrupt end, Secretary of State Marco Rubio issued a ...

At today's confirmation hearing, Democratic senators were skeptical of the HHS Secretary nominee Robert F. Kennedy Jr.'s ...

Some regulatory changes are already set to happen this year, but reduced regulation under the new administration could have a ripple effects in healthcare. Meanwhile, artificial intelligence is likely ...